Safety and Efficacy of the Modified Vaccinia Ankara–Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis
Viral Immunology · 2024
DOI: 10.1089/vim.2023.0147 ↗At a glance
Systematische Übersicht in Viral Immunology, 2024. Written by Yi Pang and 6 co-authors. Institution: Science and Technology Department, Youjiang Medical University for Nationalities, Baise, China. Major MEDLINE topics: Vaccine Efficacy, Vaccines, Attenuated. Cited 8 times so far (Crossref); 11 references.
Abstract (original language)
In May 2022, mpox began to spread worldwide, posing a serious threat to human public health. Modified Vaccinia Ankara-Bavaria Nordic (MVA-BN) is a live attenuated orthopoxvirus vaccine that has been authorized by the U.S. Food and Drug Administration as the vaccine of choice for the prevention of mpox. In this study, we conducted a meta-analysis of all currently published literature on the efficacy and safety of the MVA-BN vaccine in the real world, showing that the MVA-BN vaccine is effective and safe, with efficacy of up to 75% with a single dose and up to 80% with a two-dose vaccine. Meanwhile, we found that subcutaneous injection has lower local and systemic adverse events than intradermal injection, regardless of single- or two-dose vaccination, and subcutaneous injection is better tolerated in children, the elderly, or people with underlying medical conditions. These results have important reference value for clinical practice.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Science and Technology Department, Youjiang Medical University for Nationalities, Baise, China.
- Clinicopathological Diagnosis & Research Center, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
- Key Laboratory of Tumor Molecular Pathology of Guangxi Higher Education Institutes, Baise, China.
ORCID profiles: Yulei Li
Cite
APA
Pang, Y., Cao, D., Zhu, X., Long, Q., Tian, F., Long, X., & Li, Y. (2024). Safety and Efficacy of the Modified Vaccinia Ankara–Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis. Viral Immunology. https://doi.org/10.1089/vim.2023.0147
Vancouver
Pang Y, Cao D, Zhu X, Long Q, Tian F, Long X, et al. Safety and Efficacy of the Modified Vaccinia Ankara–Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis. Viral Immunology. 2024. doi:10.1089/vim.2023.0147
BibTeX
@article{Pang2024,
author = {Pang, Yi and Cao, Demin and Zhu, Xiaoying and Long, Qinqin and Tian, Fengqin and Long, Xidai and Li, Yulei},
title = {Safety and Efficacy of the Modified Vaccinia Ankara–Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis},
journal = {Viral Immunology},
year = {2024},
doi = {10.1089/vim.2023.0147}
}
EUVIMED